Additional $5 million from Hatteras Venture Partners supports advancement of Phase 1/2 clinical trial of INX-315 in patients ...
Cyclin-dependent kinase 6 (CDK6) plays a crucial role in the G1 phase to S phase transition of the cell cycle. Aberrant activation of CDK6 has been linked with the development and progression of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results